๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Active Rheumatoid Arthritis

Twenty-four Hour Movement Behaviors and Atherosclerotic Risk NCT07774507n/a1 site๐Ÿ“ Presidente Prudente Sรฃo Paulo State University Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL NCT07554820Phase 41 site๐Ÿ“ Lahore Shaikh Zayed Hospital, Lahore ยท Tests: Tofacitinib 5 MG A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis NCT06972446Phase 296 sites๐Ÿ“ Peoria๐Ÿ“ Jonesboro๐Ÿ“ Beverly Hills AbbVie ยท Tests: Lutikizumab, Placebo, Ravagalimab Statins and ARBs on Rheumatoid Activity NCT03770702Phase 31 site๐Ÿ“ Tanta Sherief Abd-Elsalam ยท Tests: Angiotensin receptor blockers, Statins Clinical Outcomes Study of the Nexel Total Elbow NCT02469662NA11 sites๐Ÿ“ Golden๐Ÿ“ Charlotte๐Ÿ“ Philadelphia Zimmer Biomet ยท Tests: Nexel Total Elbow JAK Inhibitor Dose TAPering Strategy Study NCT06687551Phase 424 sites๐Ÿ“ Toulouse๐Ÿ“ Amiens๐Ÿ“ Bordeaux University Hospital, Toulouse ยท Tests: Baricitinib (LY3009104) 4 mg, filgotinib 200mg/day, Tofacitinib 5 mg twice daily, Upadacitinib 15 MG, Baricitinib (LY30โ€ฆ REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases NCT07160231Phase 47 sites๐Ÿ“ Nijmegen๐Ÿ“ Maastricht๐Ÿ“ Tilburg Sint Maartenskliniek ยท Tests: JAKi dose reduction strategy, JAKi disease activity guided continuation of same dose strategy Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis NCT06301373NA5 sites๐Ÿ“ Foshan๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Methotrexate Combined With Tofacitinib, Methotrexate Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis NCT06492200NA1 site๐Ÿ“ Wรผrzburg Wuerzburg University Hospital ยท Tests: Psyllium husks Fucoidan in the Treatment of Active Rheumatoid Arthritis NCT07045896NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Fucoidan Fexofenadine in Patients With Active Rheumatoid Arthritis NCT05264025Phase 1, Phase 22 sites๐Ÿ“ Banฤซ Suwayf๐Ÿ“ Banฤซ Suwayf October 6 University ยท Tests: Fexofenadine, Placebo Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis NCT06003283Phase 47 sites๐Ÿ“ Merksem๐Ÿ“ Brussels๐Ÿ“ Genk Universitaire Ziekenhuizen KU Leuven ยท Tests: Rituximab Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors NCT07802678Phase 44 sites๐Ÿ“ Nijmegen๐Ÿ“ Tilburg๐Ÿ“ Amsterdam Sint Maartenskliniek ยท Tests: Strategy to attempt discontinuation of MTX or LEF (and restart when necessary), Continuation of MTX or LEF Dose Response of Exercise for Arthritis Management NCT06880653NA1 site๐Ÿ“ Columbia University of South Carolina ยท Tests: DREAM Adaptive Intervention Autoreactive Anti-Ro/SSA IgE To Determine Primary SjรถgRen's Syndrome's Disease Activity NCT03003572n/a8 sites๐Ÿ“ Bourgoin๐Ÿ“ Clermont-Ferrand๐Ÿ“ Grenoble Centre Hospitalier Universitaire de Saint Etienne ยท Tests: Blood samples A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis NCT07684157Phase 21 site๐Ÿ“ Beijing Jacobio Pharmaceuticals Co., Ltd. ยท Tests: JAB-8263, JAB-8263 Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis NCT07408024Phase 21 site๐Ÿ“ Beijing Toll Biotech Co. Ltd. (Beijing) ยท Tests: TollB-001, Placebo Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT NCT07438652NA1 site๐Ÿ“ Cairo Kasr El Aini Hospital ยท Tests: Mediterranean Diet (MD), Paleolithic Diet (PD), Control (Usual Diet) A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naรฏve Participants Participants With Early Rheumatoid Arthritis NCT06671054Phase 211 sites๐Ÿ“ Cutler Bay๐Ÿ“ Miami๐Ÿ“ Duncansville SynAct Pharma Aps ยท Tests: AP1189, 40 mg, AP1189, 70 mg, AP1189, 100 mg, AP1189 matching placebo A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY) NCT07409103Phase 234 sites๐Ÿ“ Gilbert๐Ÿ“ Glendale๐Ÿ“ Tucson Elevara Medicines Limited ยท Tests: ELV001 25 mg, ELV001 75 mg, ELV001 125 mg, Placebo Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection The Effect of Nicorandil on Rheumatoid Arthritis Patients NCT07730723Phase 2, Phase 31 site๐Ÿ“ Cairo Ain Shams University ยท Tests: Nicorandil Oral Tablet, Placebo, conventional synthetic antirheumatic drugs (cDMARDs) Gluten-Free vs Mediterranean Diet in Rheumatoid Arthritis NCT07646262NA1 site๐Ÿ“ Gaziantep Hasan Kalyoncu University ยท Tests: Gluten-Free Diet Group, Mediterranean Diet, Control Diet A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases NCT06570798Phase 258 sites๐Ÿ“ Scottsdale๐Ÿ“ Aurora๐Ÿ“ Hialeah Amgen ยท Tests: Inebilizumab, Blinatumomab Phase 3 Study of Telitacicept in Active Primary Sjรถgren's Disease NCT07404865Phase 349 sites๐Ÿ“ Chandler๐Ÿ“ Flagstaff๐Ÿ“ Glendale Vor Biopharma ยท Tests: Telitacicept, Placebo The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection NCT07001956EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: UTAA91 injection A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease NCT07041099Phase 114 sites๐Ÿ“ Orlando๐Ÿ“ Brooklyn๐Ÿ“ Memphis Cullinan Therapeutics Inc. ยท Tests: CLN-978 Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis NCT07347860EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: A-319 MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients With Active Rheumatoid Arthritis NCT06649136Phase 41 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Methotrexate Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD NCT07423533Phase 21 site๐Ÿ“ Beijing Changchun GeneScience Pharmaceutical Co., Ltd. ยท Tests: GenSci120 150 mg, GenSci120 600 mg, GenSci120 1000 mg, adalimumab injection 40 mg, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy